Since only one article included in this meta-analysis reported on the prognostic significance of specific KRAS mutations in codons 12 and 13, we were unable to further analyze the potential relationship between these specific mutations and CRC prognosis. This evidence concerns the gene KRAS and colorectal carcinoma.